Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients by V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Subjects: “…chronic myelogenous leukemia…”
Get full text

Association of Chronic Myelogenous (Basophilic) Leukemia and the BCR/ABL Mutation in a Yucatan Barrow (Sus scrofa domestica) by Catherine Takawira, Carmen B. Arsuaga-Zorrilla, Leslie Wilson, Takashi Taguchi, Marilyn A. Dietrich, Rhett W. Stout, Mandi J. Lopez

Subjects: Get full text

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors by Tatsuki Shibuta, Honoka Shimizu, Yukichi Takada, Asuka Fuku, Satoshi Tomiyasu, Tsukuru Umemura

Subjects: “…chronic myelogenous leukemia…”
Get full text

P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS by Seiichi Okabe, Mitsuru Moriyama, Akihiko Gotoh

Get full text

A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb by Bin Zhang, Ting Zhang, Tian-Yi Zhang, Ning Wang, Shan He, Bin Wu, Hai-Xiao Jin

“…Among a new series of acridone derivatives previously synthesized, it was found that the methoxybenzyl 5-nitroacridone derivative <b>8q</b> has nanomolar cytotoxicity in vitro against human chronic myelogenous leukemia K562 cells. In order to further explore the possible anti-leukemia mechanism of action of <b>8q</b> on K562 cells, a metabolomics and molecular biology study was introduced. …”
Get full text

Confirmed Coronavirus Disease-19 (COVID-19) in a Male with Chronic Myeloid Leukemia Complicated by Febrile Neutropenia and Acute Respiratory Distress Syndrome by Ahmed M. Abdalhadi, Awni Alshurafa, Mohammed Alkhatib, Mohamed Abou Kamar, Mohamed A. Yassin

Subjects: “…chronic myelogenous leukemia…”
Get full text

Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients by Hamza MS, Shouman SA, Abdelfattah R, Moussa HS, Omran MM

Subjects: Get full text

Sirtuin 1 inhibits lipopolysaccharide-induced inflammation in chronic myelogenous leukemia k562 cells through interacting with the Toll-like receptor 4-nuclear factor κ B-reactive oxygen species signaling axis by Lei Wang, Mingming Wang, Hongju Dou, Wenjie Lin, Lifang Zou

“…Abstract Background Chronic myelogenous leukemia (CML) is a clonal myeloproliferative neoplasm resulting from BCR–ABL-transformed hematopoietic stem cells. …”
Get full text

Coexistence of recurrent chromosomal abnormalities and the Philadelphia chromosome in acute and chronic myeloid leukemias: report of five cases and review of literature by Jin-Ying Gong, Zhen-Hao Zhang, Wei Zhang, Hui-Jun Wang, Xiao-Fang Feng, Ji Zhou, Guo-Qing Zhu

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil by Fernando Callera, Alexandra Fernandes Callera, Evandro Secchi Rosa

Subjects: Get full text

Chronic Myeloid Leukemia with b3a3 (e14a3) Fusion: A Rare BCR/ABL Rearrangement Presenting with Thrombocytosis – Does MTHFR Polymorphism Matter by Mohammad Muhsin Chisti, Daniel Steven Sanders

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update by Robert Roskoski, Jr.

Subjects: Get full text

Semi-Synthesis, Cytotoxic Evaluation, and Structure—Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity by Xu-Xiu Lu, Yao-Yao Jiang, Yan-Wei Wu, Guang-Ying Chen, Chang-Lun Shao, Yu-Cheng Gu, Ming Liu, Mei-Yan Wei

Subjects: Get full text

The molecular basis of Abelson kinase regulation by its αI-helix by Johannes Paladini, Annalena Maier, Judith Maria Habazettl, Ines Hertel, Rajesh Sonti, Stephan Grzesiek

Subjects: Get full text

PB1902: ASC4OPT TRIAL IN PROGRESS: A PHASE 3B OPEN-LABEL OPTIMIZATION STUDY OF ORAL ASCIMINIB IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE PREVIOUSLY TREATED WITH 2 OR MORE TYROSINE KINASE INHIBITORS by M. Breccia, A. Turkina, C. Boquimpani, C. Chuah, G. Sharf, P. Schuld, M. Hoch, J. Yssel, Y. Zhang, A. Hochhaus

Get full text

Fluorescence In situ hybridization signal patterns and intrachromosomal breakpoint cluster region-abelson murine leukemia viral oncogene homolog 1 amplification analysis in imatinib-resistant chronic myelogenous leukemia patients using tricolor dual fusion probe by Karthik B K. Bommannan, Shano Naseem, Neelam Varma, Jogeshwar Binota, Pankaj Malhotra, Subhash Varma

Subjects: Get full text

Profiling of Metabolic Differences between Hematopoietic Stem Cells and Acute/Chronic Myeloid Leukemia by Byung Hoo Song, Su Young Son, Hyun Kyu Kim, Tae Won Ha, Jeong Suk Im, Aeli Ryu, Hyeji Jeon, Hee Yong Chung, Jae Sang Oh, Choong Hwan Lee, Man Ryul Lee

Subjects: Get full text

Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada by Leonard Tu Nguyen, Maggie Guo, Christopher Naugler, Fariborz Rashid-Kolvear

Subjects: Get full text

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells by Paola Pacelli, Adele Santoni, Anna Sicuranza, Elisabetta Abruzzese, Valentina Giai, Monica Crugnola, Mario Annunziata, Sara Galimberti, Alessandra Iurlo, Luigiana Luciano, Federica Sorà, Carmen Fava, Elena Bestoso, Cristina Marzano, Alessandra Cartocci, Marzia Defina, Vincenzo Sammartano, Emanuele Cencini, Donatella Raspadori, Monica Bocchia

Subjects: “…chronic myelogenous leukemia…”
Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Subjects: “…chronic myelogenous leukemia…”
Get full text